Posts

Showing posts with the label Bupivacaine

Our Scalp Block Results in Craniotomy Cases-Juniper Publishers

Image
Juniper Publishers - Journal of Anesthesia Abstract Aim: The aim of this study is to investigate the effect of scalp block performed with 0,5% of bupivacaine in craniotomy cases in preventing hemodynamic response due to the incision and its effect on postoperative analgesia and the need of analgesics. Materials and method: The study was planned as a randomized, placebo controlled, double-blind study. 40 patients between the ages of 40-85 with ASA II-III classification were included in the study for elective craniotomy after the approval of the ethics committee and informed consents of the patients were received and they were separated into two groups (Group S: 20ml 0,9% normal saline, n=20), (Group B: 20ml0, 5% Bupivakain, n=20). Scalp block was performed 15 minutes before craniotomy. The mean arterial pressure (MAP) and heart rate (HR) of the patients wererecorded. Postoperative complications observed in the recovery room (bradycardia, hypotension, drug allergy...

Clinical Efficacy of Clonidine versus Fentanyl as Spinal Adjuvant to 0.5% Hyperbaric Bupivacaine for Knee Arthroscopy under Subarachnoid Block- A Comparative Evaluation-Juniper Publishers

Image
Juniper Publishers - Journal of Anesthesia Abstract Background: Neuraxial techniques are safe and possess many benefits with drawback of short duration of anesthetic action. A small mass of local anesthetic can produce profound and reproducible surgical anesthesia. The present was aimed to compare the clinical efficacy and safety of clonidine versus fentanyl as spinal adjuvant to 0.5% hyperbaric bupivacaine for knee arthroscopy. Patients and Method: Sixty adult patients of American Society of Anaesthesiologists (ASA) physical status I and II of both genders, aged 18 to 58 years, were randomized into two groups of 30 patients each to receive either with 0.5 ml of clonidine, 30 μg (Group I BC) or 0.5 ml of fentanyl, 25 μg (Group II BF) with 3.5 mL0.5% hyperbaric bupivacaine. Sensory and motor block characteristics and time to first rescue analgesic (i.v. tramadol 100 mg) were recorded as primary end points. Drug related side effects of pruritus, nausea, vomiting a...